302 related articles for article (PubMed ID: 25527621)
1. Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironment.
Lee YC; Gajdosik MS; Josic D; Clifton JG; Logothetis C; Yu-Lee LY; Gallick GE; Maity SN; Lin SH
Mol Cell Proteomics; 2015 Mar; 14(3):471-83. PubMed ID: 25527621
[TBL] [Abstract][Full Text] [Related]
2. BMP4 promotes prostate tumor growth in bone through osteogenesis.
Lee YC; Cheng CJ; Bilen MA; Lu JF; Satcher RL; Yu-Lee LY; Gallick GE; Maity SN; Lin SH
Cancer Res; 2011 Aug; 71(15):5194-203. PubMed ID: 21670081
[TBL] [Abstract][Full Text] [Related]
3. A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.
Fong EL; Wan X; Yang J; Morgado M; Mikos AG; Harrington DA; Navone NM; Farach-Carson MC
Biomaterials; 2016 Jan; 77():164-72. PubMed ID: 26599623
[TBL] [Abstract][Full Text] [Related]
4. Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions.
Li X; Sterling JA; Fan KH; Vessella RL; Shyr Y; Hayward SW; Matrisian LM; Bhowmick NA
Mol Cancer Res; 2012 Apr; 10(4):494-503. PubMed ID: 22290877
[TBL] [Abstract][Full Text] [Related]
5. Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases.
Kirschenbaum A; Izadmehr S; Yao S; O'Connor-Chapman KL; Huang A; Gregoriades EM; Yakar S; Levine AC
Endocrinology; 2016 Dec; 157(12):4526-4533. PubMed ID: 27783536
[TBL] [Abstract][Full Text] [Related]
6. Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC-0449 in the bone forming prostate cancer xenograft MDA PCa 118b.
Karlou M; Lu JF; Wu G; Maity S; Tzelepi V; Navone NM; Hoang A; Logothetis CJ; Efstathiou E
Prostate; 2012 Nov; 72(15):1638-47. PubMed ID: 22457212
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature.
Mohamedali KA; Li ZG; Starbuck MW; Wan X; Yang J; Kim S; Zhang W; Rosenblum MG; Navone NM
Clin Cancer Res; 2011 Apr; 17(8):2328-38. PubMed ID: 21343372
[TBL] [Abstract][Full Text] [Related]
8. Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer.
Lin SC; Lee YC; Yu G; Cheng CJ; Zhou X; Chu K; Murshed M; Le NT; Baseler L; Abe JI; Fujiwara K; deCrombrugghe B; Logothetis CJ; Gallick GE; Yu-Lee LY; Maity SN; Lin SH
Dev Cell; 2017 Jun; 41(5):467-480.e3. PubMed ID: 28586644
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
Yang J; Fizazi K; Peleg S; Sikes CR; Raymond AK; Jamal N; Hu M; Olive M; Martinez LA; Wood CG; Logothetis CJ; Karsenty G; Navone NM
Cancer Res; 2001 Jul; 61(14):5652-9. PubMed ID: 11454720
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer cells and bone stromal cells mutually interact with each other through bone morphogenetic protein-mediated signals.
Nishimori H; Ehata S; Suzuki HI; Katsuno Y; Miyazono K
J Biol Chem; 2012 Jun; 287(24):20037-46. PubMed ID: 22532569
[TBL] [Abstract][Full Text] [Related]
12. Osteoblast-secreted WISP-1 promotes adherence of prostate cancer cells to bone via the VCAM-1/integrin α4β1 system.
Chang AC; Chen PC; Lin YF; Su CM; Liu JF; Lin TH; Chuang SM; Tang CH
Cancer Lett; 2018 Jul; 426():47-56. PubMed ID: 29627497
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6: a bone marrow stromal cell paracrine signal that induces neuroendocrine differentiation and modulates autophagy in bone metastatic PCa cells.
Delk NA; Farach-Carson MC
Autophagy; 2012 Apr; 8(4):650-63. PubMed ID: 22441019
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion.
Wang W; Yang X; Dai J; Lu Y; Zhang J; Keller ET
Oncogene; 2019 Jun; 38(23):4540-4559. PubMed ID: 30755731
[TBL] [Abstract][Full Text] [Related]
15. Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A.
Hashimoto K; Ochi H; Sunamura S; Kosaka N; Mabuchi Y; Fukuda T; Yao K; Kanda H; Ae K; Okawa A; Akazawa C; Ochiya T; Futakuchi M; Takeda S; Sato S
Proc Natl Acad Sci U S A; 2018 Feb; 115(9):2204-2209. PubMed ID: 29440427
[TBL] [Abstract][Full Text] [Related]
16. Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.
Sharma S; Xing F; Liu Y; Wu K; Said N; Pochampally R; Shiozawa Y; Lin HK; Balaji KC; Watabe K
J Biol Chem; 2016 Sep; 291(37):19351-63. PubMed ID: 27422817
[TBL] [Abstract][Full Text] [Related]
17. MAOA-Dependent Activation of Shh-IL6-RANKL Signaling Network Promotes Prostate Cancer Metastasis by Engaging Tumor-Stromal Cell Interactions.
Wu JB; Yin L; Shi C; Li Q; Duan P; Huang JM; Liu C; Wang F; Lewis M; Wang Y; Lin TP; Pan CC; Posadas EM; Zhau HE; Chung LWK
Cancer Cell; 2017 Mar; 31(3):368-382. PubMed ID: 28292438
[TBL] [Abstract][Full Text] [Related]
18. Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone.
Li ZG; Yang J; Vazquez ES; Rose D; Vakar-Lopez F; Mathew P; Lopez A; Logothetis CJ; Lin SH; Navone NM
Oncogene; 2008 Jan; 27(5):596-603. PubMed ID: 17700537
[TBL] [Abstract][Full Text] [Related]
19. Cooperation among heterogeneous prostate cancer cells in the bone metastatic niche.
Shahriari K; Shen F; Worrede-Mahdi A; Liu Q; Gong Y; Garcia FU; Fatatis A
Oncogene; 2017 May; 36(20):2846-2856. PubMed ID: 27991924
[TBL] [Abstract][Full Text] [Related]
20. Metastatic Prostate Cancer Cells Secrete Methylglyoxal-Derived MG-H1 to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A Possible Novel Player in Prostate Cancer Bone Metastases.
Antognelli C; Marinucci L; Frosini R; Macchioni L; Talesa VN
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
